Report : Whole Slide Imaging Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type (Hardware, Software, and Services); Application (Telepathology, Cytopathology, Immunohistochemistry, and Hematopathology); End User (Hospitals, Pharmaceutical and Biopharmaceutical Companies, Laboratories, and Academic Research Institutes)
Hardware Segment to Register Highest CAGR during 2020–2027
According to our latest study on “Whole Slide Imaging Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Type, Application, and End User,” the market was valued at US$ 419.52 million in 2019 and is projected to reach US$ 1,582.12 million by 2027; it is expected to grow at a CAGR of 18.1% during 2020–2027. The report highlights trends prevailing in the global whole slide imaging market, and the factors driving and restraining the market growth.
The global whole slide imaging market, based on type, is segmented into hardware, software and services. In 2019, the hardware segment accounted for the highest share of the market. The market growth for this segment is attributed to the increasing adoption of digital pathologies and rising demand for digital pathology infrastructure.
The growth of the whole slide imaging market is driven by the technological advancements in whole slide imaging and increasing adoption of digital pathology. However, the high cost associated with installation and maintenance of whole slide imaging restrains the growth of the market. 3DHISTECH Ltd., Indica Labs, Inspirata, Inc., Koninklijke Philips N.V., Hamamatsu Photonics K.K., Olympus, Nikon, Danaher (Leica Biosystems), Mikroscan Technologies, Inc., Visiopharm AS, and Akoya Biosciences, Inc are among the companies operating in the market.
The report segments global whole slide imaging market as follows:
By End User